Ovarian Reserve Panel in UAE | 750 AED | DHA Licensed

Executive Summary & Core Metrics

✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
✓ Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy (8 AM – 11 PM).
✓ Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed specialists.
✓ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

The Ovarian Reserve Panel is a comprehensive diagnostic assessment that quantifies a woman's remaining ovarian follicular pool using serum biomarkers including Anti-Müllerian Hormone (AMH), Follicle-Stimulating Hormone (FSH), and Estradiol (E2), analysed via CLIA and ELISA/EIA methodologies. This panel provides clinically validated metrics for fertility planning, perimenopause staging, and pre-IVF workup.

Test Overview & Methodology

The Ovarian Reserve Panel measures AMH, FSH, and E2 in serum using dual-platform CLIA (Chemiluminescent Immunoassay) and ELISA/EIA with LC-MS/MS reflex capability. This combined approach ensures 99.9% diagnostic sensitivity and robust cross-validation. The panel is essential for evaluating ovarian ageing, diagnosing polycystic ovary syndrome (PCOS) contributions, and monitoring response to fertility treatments.

Feature	Our Ovarian Reserve Panel	Closest Alternative
Precision	99.9% Diagnostic Sensitivity; dual-platform CLIA + ELISA/EIA cross-validation	Single-platform immunoassay; ~92–95% sensitivity
Methodology	CLIA (Chemiluminescent Immunoassay) + ELISA/EIA with LC-MS/MS reflex capability	Standard EIA only; no orthogonal confirmation
Turnaround Time	Same-day reporting (sample by 9 AM; report by evening)	24–72 hours
Pre-test Guidance	Cycle-day specification + telephonic pre-test counselling included	Cycle-day notation only; no counselling
Home Collection	ISO-certified cold-chain VIP phlebotomy (8 AM – 11 PM)	Standard courier; no cold-chain guarantee

Physician Insight & Safety Protocols

Dr. Ajay Singh (DHA License: 36234132) — "The Ovarian Reserve Panel is a powerful screening tool, yet it must always be correlated with transvaginal ultrasound findings, age, and comprehensive reproductive history. A single abnormal value does not define fertility potential; I urge every patient to review results in consultation with a qualified endocrinologist or gynaecologist before drawing conclusions."

Advisory & Medication Precautions

Before undergoing the Ovarian Reserve Panel, disclose all hormonal medications—including oral contraceptives, hormone replacement therapy (HRT), GnRH agonists/antagonists, and over-the-counter DHEA or phytoestrogen supplements. Hormonal contraceptives can significantly lower AMH levels; a washout period of 4–6 weeks is recommended if accurate baseline assessment is needed. Never discontinue prescribed medications without consulting your doctor.

Exclusion Criteria & Emergency Red Flags

Exclusion Criteria (Do Not Proceed Without Physician Clearance):

Confirmed or suspected pregnancy
Active use of combined hormonal contraceptives (washout period: 4–6 weeks minimum)
Recent ovarian surgery or ovarian cystectomy (within 8 weeks)
Known ovarian neoplasm or adnexal mass under active investigation
Current GnRH agonist/antagonist therapy

Emergency Red Flags — Seek Immediate Medical Attention If:

Acute, severe pelvic or lower abdominal pain
Sudden abdominal distension or bloating with nausea
Signs of ovarian torsion (sharp unilateral pain with vomiting)
Symptoms of ovarian hyperstimulation syndrome (OHSS)
Heavy vaginal bleeding unrelated to menses

Patient FAQ & Clinical Guidance

1. What does the Ovarian Reserve Panel actually measure, and why is it important?

The Ovarian Reserve Panel measures Anti-Müllerian Hormone (AMH), Follicle-Stimulating Hormone (FSH), and Estradiol (E2) levels in serum to quantitatively assess the remaining follicular pool and ovarian ageing status. These biomarkers, when interpreted together, provide a clinically validated snapshot of reproductive potential. AMH reflects the primordial follicle count and declines predictably with age, while FSH and E2 offer complementary insight into hypothalamic-pituitary-ovarian axis function. The panel is essential for fertility planning, perimenopause staging, and pre-IVF workup.

2. On which day of my menstrual cycle should I take this test?

AMH can be drawn on any day of the menstrual cycle with negligible variation, while FSH and Estradiol are optimally measured on Day 2, 3, or 4 of a spontaneous menstrual cycle for accurate basal assessment. If you have irregular cycles or amenorrhoea, the test can proceed regardless of cycle day; simply note the LMP date on the requisition form. Our DHA-licensed phlebotomists will verify cycle-day documentation at the time of collection to ensure result validity.

3. How reliable is this panel, and what do abnormal results mean for my fertility?

With 99.9% diagnostic sensitivity under ISO 9001:2015 accredited protocols, this panel is among the most reliable ovarian reserve assessments available in the UAE, yet abnormal results must always be correlated clinically with ultrasound antral follicle count (AFC) and specialist evaluation. A low AMH or elevated basal FSH may suggest diminished ovarian reserve but does not independently diagnose infertility. Conversely, a normal result does not guarantee conception. All results include access to a telephonic post-test clinical guidance session with a DHA-registered endocrinology consultant to contextualise findings within your personal health profile.

UAE Regulatory & Data Privacy Adherence

Regulatory Compliance & Data Protection

This diagnostic service is fully compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability. The laboratory is ISO 9001:2015 certified (Certificate INT/EGQ/2509DA/3139). All home collection phlebotomists hold active DHA licensure. Modern equivalent confirmatory testing available via LC-MS/MS reflex where clinically indicated.

Clinical & Logistical Metadata

Test Name	Ovarian Reserve Panel (AMH, FSH, Estradiol)
Price (AED)	750 AED
Turnaround Time	Same-day reporting (sample by 9 AM)
Sample Type / Matrix	3 mL serum (SST tube); refrigerated transport
Methodology Used	CLIA + ELISA/EIA with LC-MS/MS reflex
ICD-10-CM Code	E28.8, E28.9, Z31.41
LOINC Code	87688-4
DHA Facility License & Laboratory Address	DHA License: 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE — DNA Labs UAE